About SAB Biotherapeutics, Inc. 
SAB Biotherapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 5 Schemes (6.26%)
Foreign Institutions
Held by 12 Foreign Institutions (2.06%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-19 Million
Pharmaceuticals & Biotechnology
USD 196 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.63
-49.91%
1.30






